Owners, management and financials
CVR: 43007068
Previous names: Warburg Oncology ApS
DKK -1,687,751
Gross profit
Net result: DKK -4,355,625
John Sørensen Haurum (10-14,99%), Stine Helene Falsig Petersen (10-14,99%)
5 more
CVR · view owners
John Sørensen Haurum
Board: John Sørensen Haurum (chair) and 2 members
CVR · view management
Active
Founded 21 January 2022
CVR · view overview
3 employees
CVR · 2026
Director registered: John Sørensen Haurum
CVR · 28/08/2025
View the full event history
Solid Therapeutics ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2022. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Warburg Oncology ApS. The management consists of John Sørensen Haurum. The board consists of John Sørensen Haurum (chair), Claus Haase and Thue Walter Schwartz. The company's owners include John Sørensen Haurum, Stine Helene Falsig Petersen and Anne Mette Hyldgaard Trauelsen. The company has 3 employees (2026). In 2025, the company reported a gross profit of DKK -1,687,751 and a net result of DKK -4,355,625 compared with DKK -6,758,207 the year before. Equity in the 2025 report amounted to DKK -15,353,766.
Selskabets formål er at udøve aktiviteter indenfor fund af lægemidler og udvikling heraf.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | -1.7 mio. | -4.4 mio. | 6.8 mio. | -15.4 mio. | 3 | |
| 202401/01/2024 – 31/12/2024 | -4.2 mio. | -6.8 mio. | 11 mio. | -11 mio. | 4 | |
| 202301/01/2023 – 31/12/2023 | -2.7 mio. | -3.5 mio. | 10.8 mio. | -4.2 mio. | 2 | |
| 202221/01/2022 – 31/12/2022 | -398 t. | -797 t. | 3.6 mio. | -757 t. | 1 |
Compared to 1.038 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationThe CVR number of Solid Therapeutics ApS is 43007068.
The owners of Solid Therapeutics ApS include John Sørensen Haurum, Stine Helene Falsig Petersen and Anne Mette Hyldgaard Trauelsen.
The management of Solid Therapeutics ApS consists of John Sørensen Haurum.
The board of Solid Therapeutics ApS consists of John Sørensen Haurum, Claus Haase and Thue Walter Schwartz, with John Sørensen Haurum as chair.
In 2025, Solid Therapeutics ApS reported a gross profit of DKK -1,687,751.
Solid Therapeutics ApS had 3 employees in 2026 according to the Danish CVR register.
Claim this page to add your logo and social links. Free to get started.
Solid Therapeutics ApS has published its annual report for 2025. Gross profit came to DKK -1,687,751, and the net result was DKK -4,355,625.
As of August 28, 2025, John Sørensen Haurum is registered as adm. dir. of Solid Therapeutics ApS.
As of August 28, 2025, Anne Mette Hyldgaard Trauelsen has stepped down as adm. dir. of Solid Therapeutics ApS.
Solid Therapeutics ApS has published its annual report for 2024. Gross profit came to DKK -4,213,656, and the net result was DKK -6,758,207.
Solid Therapeutics ApS has published its annual report for 2023. Gross profit came to DKK -2,738,806, and the net result was DKK -3,483,115.
As of December 7, 2023, LPOG ApS STATSAUTORISEREDE REVISORER has been appointed auditor of Solid Therapeutics ApS.
Solid Therapeutics ApS has published its annual report for 2022. Gross profit came to DKK -397,812, and the net result was DKK -796,818.
As of February 1, 2023, Anne Mette Hyldgaard Trauelsen is registered as adm. dir. of Solid Therapeutics ApS.
As of February 1, 2023, John Sørensen Haurum has stepped down as director of Solid Therapeutics ApS.
On February 1, 2023, the company changed its name from Warburg Oncology ApS to Solid Therapeutics ApS.
As of February 1, 2023, Stine Helene Falsig Petersen is registered as an owner of Solid Therapeutics ApS with an ownership share of 10%.
As of February 1, 2023, Anne Mette Hyldgaard Trauelsen is registered as an owner of Solid Therapeutics ApS with an ownership share of 20%.
As of February 1, 2023, is registered as an owner of Solid Therapeutics ApS with an ownership share of 10%.
As of February 21, 2022, John Sørensen Haurum is registered as director of Solid Therapeutics ApS.
As of February 21, 2022, Claus Haase has stepped down as director of Solid Therapeutics ApS.
As of January 21, 2022, John Sørensen Haurum has joined the board of directors of Solid Therapeutics ApS.
As of January 21, 2022, Thue Walter Schwartz has joined the board of directors of Solid Therapeutics ApS.
As of January 21, 2022, Claus Haase has joined the board of directors of Solid Therapeutics ApS.
As of January 21, 2022, Claus Haase is registered as director of Solid Therapeutics ApS.
As of January 21, 2022, John Sørensen Haurum is registered as an owner of Solid Therapeutics ApS with an ownership share of 10%.
As of January 21, 2022, Receptor Holding ApS is registered as an owner of Solid Therapeutics ApS with an ownership share of 20%.
As of January 21, 2022, Frimurer Holdings ApS is registered as an owner of Solid Therapeutics ApS with an ownership share of 20%.
As of January 21, 2022, Haase Invest ApS is registered as an owner of Solid Therapeutics ApS with an ownership share of 10%.
Solid Therapeutics ApS was founded on January 21, 2022.
Uneven Bits ApS is an independent IT consultancy founded and operated by Klaus Byskov Pedersen. With deep expertise in software architecture and systems design, I help organizations build robust, scalable, and maintainable technical solutions. Whether you need strategic guidance on technology decisions, hands-on architecture work, or help navigating complex technical challenges, I bring focused expertise and a practical approach to every engagement.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Selskabets formål er at udvikle, markedsføre, sælge og implementere software produkter til brug ved indkøbsstyring og dermed efter bestyrelsens skøn beslægtet virksomhed
Selskabets formål er IT- og kommunikationsvirksomhed samt virksomhed i øvrigt, der efter bestyrelsens skøn står i forbindelse hermed.
Companies in the same industry and area
CVR 36465972
CVR 45436497
CVR 46059220
CVR 41978074
CVR 46543912
